87 related articles for article (PubMed ID: 21136776)
1. Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer.
Chang JW; Kang UB; Kim DH; Yi JK; Lee JW; Noh DY; Lee C; Yu MH
Proteomics Clin Appl; 2008 Jan; 2(1):23-32. PubMed ID: 21136776
[TBL] [Abstract][Full Text] [Related]
2. BMP-1/Tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan.
Gonzalez EM; Reed CC; Bix G; Fu J; Zhang Y; Gopalakrishnan B; Greenspan DS; Iozzo RV
J Biol Chem; 2005 Feb; 280(8):7080-7. PubMed ID: 15591058
[TBL] [Abstract][Full Text] [Related]
3. LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy.
Surin B; Sachon E; Rougier JP; Steverlynck C; Garreau C; Lelongt B; Ronco P; Piedagnel R
Proteomics; 2013 Jan; 13(1):142-52. PubMed ID: 23161552
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the LG3 domain of endorepellin, an angiogenesis inhibitor.
Le BV; Kim H; Choi J; Kim JH; Hahn MJ; Lee C; Kim KK; Hwang HY
J Mol Biol; 2011 Nov; 414(2):231-42. PubMed ID: 21996443
[TBL] [Abstract][Full Text] [Related]
5. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes.
Wu CC; Chen HC; Chen SJ; Liu HP; Hsieh YY; Yu CJ; Tang R; Hsieh LL; Yu JS; Chang YS
Proteomics; 2008 Jan; 8(2):316-32. PubMed ID: 18203259
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
Chung JC; Oh MJ; Choi SH; Bae CD
ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
[TBL] [Abstract][Full Text] [Related]
7. A fragment of the LG3 peptide of endorepellin is present in the urine of physically active mining workers: a potential marker of physical activity.
Parker TJ; Sampson DL; Broszczak D; Chng YL; Carter SL; Leavesley DI; Parker AW; Upton Z
PLoS One; 2012; 7(3):e33714. PubMed ID: 22457785
[TBL] [Abstract][Full Text] [Related]
8. The perlecan fragment LG3 is a novel regulator of obliterative remodeling associated with allograft vascular rejection.
Soulez M; Pilon EA; Dieudé M; Cardinal H; Brassard N; Qi S; Wu SJ; Durocher Y; Madore F; Perreault C; Hébert MJ
Circ Res; 2012 Jan; 110(1):94-104. PubMed ID: 22076637
[TBL] [Abstract][Full Text] [Related]
9. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.
Whiteaker JR; Zhang H; Zhao L; Wang P; Kelly-Spratt KS; Ivey RG; Piening BD; Feng LC; Kasarda E; Gurley KE; Eng JK; Chodosh LA; Kemp CJ; McIntosh MW; Paulovich AG
J Proteome Res; 2007 Oct; 6(10):3962-75. PubMed ID: 17711321
[TBL] [Abstract][Full Text] [Related]
10. Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA).
Hamrita B; Chahed K; Kabbage M; Guillier CL; Trimeche M; Chaïeb A; Chouchane L
Clin Chim Acta; 2008 Jul; 393(2):95-102. PubMed ID: 18424265
[TBL] [Abstract][Full Text] [Related]
11. Expression of fibrinogen E-fragment and fibrin E-fragment is inhibited in the human infiltrating ductal carcinoma of the breast: the two-dimensional electrophoresis and MALDI-TOF-mass spectrometry analyses.
Chahed K; Kabbage M; Ehret-Sabatier L; Lemaitre-Guillier C; Remadi S; Hoebeke J; Chouchane L
Int J Oncol; 2005 Nov; 27(5):1425-31. PubMed ID: 16211239
[TBL] [Abstract][Full Text] [Related]
12. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry.
Li DQ; Wang L; Fei F; Hou YF; Luo JM; ; Zeng R; Wu J; Lu JS; Di GH; Ou ZL; Xia QC; Shen ZZ; Shao ZM
Proteomics; 2006 Jun; 6(11):3352-68. PubMed ID: 16637015
[TBL] [Abstract][Full Text] [Related]
13. Identification of two-dimensionally separated human cerebrospinal fluid proteins by N-terminal sequencing, matrix-assisted laser desorption/ionization--mass spectrometry, nanoliquid chromatography-electrospray ionization-time of flight-mass spectrometry, and tandem mass spectrometry.
Raymackers J; Daniels A; De Brabandere V; Missiaen C; Dauwe M; Verhaert P; Vanmechelen E; Meheus L
Electrophoresis; 2000 Jun; 21(11):2266-83. PubMed ID: 10892737
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
15. Identification and quantification of proteins differentially secreted by a pair of normal and malignant breast-cancer cell lines.
Liang X; Huuskonen J; Hajivandi M; Manzanedo R; Predki P; Amshey JR; Pope RM
Proteomics; 2009 Jan; 9(1):182-93. PubMed ID: 19053080
[TBL] [Abstract][Full Text] [Related]
16. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
[TBL] [Abstract][Full Text] [Related]
17. Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker.
Lemaire R; Menguellet SA; Stauber J; Marchaudon V; Lucot JP; Collinet P; Farine MO; Vinatier D; Day R; Ducoroy P; Salzet M; Fournier I
J Proteome Res; 2007 Nov; 6(11):4127-34. PubMed ID: 17939699
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of microfilamental network-associated proteins in leukocytes of breast cancer patients: potential application to predictive diagnosis.
Braun M; Fountoulakis M; Papadopoulou A; Vougas K; Seidel I; Höller T; Yeghiazaryan K; Schild HH; Kuhn W; Golubnitschaja O
Cancer Genomics Proteomics; 2009; 6(1):31-40. PubMed ID: 19451088
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of exosome-like vesicles derived from breast cancer cells.
Palazzolo G; Albanese NN; DI Cara G; Gygax D; Vittorelli ML; Pucci-Minafra I
Anticancer Res; 2012 Mar; 32(3):847-60. PubMed ID: 22399603
[TBL] [Abstract][Full Text] [Related]
20. Identification of leptomeningeal metastasis-related proteins in cerebrospinal fluid of patients with breast cancer by a combination of MALDI-TOF, MALDI-FTICR and nanoLC-FTICR MS.
Römpp A; Dekker L; Taban I; Jenster G; Boogerd W; Bonfrer H; Spengler B; Heeren R; Smitt PS; Luider TM
Proteomics; 2007 Feb; 7(3):474-81. PubMed ID: 17274072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
